Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 8587

1.

The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.

Tola EN, Yalcin SE, Dugan N.

Eur J Obstet Gynecol Reprod Biol. 2017 May 15;214:168-172. doi: 10.1016/j.ejogrb.2017.05.014. [Epub ahead of print]

PMID:
28535403
2.

Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging.

Frøssing S, Nylander MC, Chabanova E, Kistorp C, Skouby SO, Faber J.

Acta Radiol. 2017 Jan 1:284185117711475. doi: 10.1177/0284185117711475. [Epub ahead of print]

PMID:
28534418
3.

The high-molecular weight multimer form of adiponectin is a useful marker of polycystic ovary syndrome in Bahraini Arab women.

Al-Awadi AM, Sarray S, Arekat MR, Saleh LR, Mahmood N, Almawi WY.

Clin Nutr ESPEN. 2016 Jun;13:e33-e38. doi: 10.1016/j.clnesp.2016.03.078. Epub 2016 Apr 20.

PMID:
28531566
4.

Is foetal hyperexposure to androgens a cause of PCOS?

Filippou P, Homburg R.

Hum Reprod Update. 2017 May 20:1-12. doi: 10.1093/humupd/dmx013. [Epub ahead of print]

PMID:
28531286
5.

L:A ratio, Insulin resistance and metabolic risk in women with polycystic ovarian syndrome.

Gupta V, Mishra S, Mishra S, Gupta V.

Diabetes Metab Syndr. 2017 May 10. pii: S1871-4021(17)30114-5. doi: 10.1016/j.dsx.2017.05.001. [Epub ahead of print]

PMID:
28529126
6.

Androsterone glucuronide to dehydroepiandrosterone sulphate ratio is discriminatory for obese Caucasian women with polycystic ovary syndrome.

Cho LW, Sathyapalan T, Kilpatrick ES, Keevil BG, Miller AG, Coady AM, Ahmed L, Atkin SL.

BMC Endocr Disord. 2017 May 19;17(1):26. doi: 10.1186/s12902-017-0177-3.

7.

Ovarian Volume in Korean Women with Polycystic Ovary Syndrome and Its Related Factors.

Han YS, Lee AR, Song HK, Choi JI, Kim JH, Kim MR, Kim MJ.

J Menopausal Med. 2017 Apr;23(1):25-31. doi: 10.6118/jmm.2017.23.1.25. Epub 2017 Apr 28.

8.

Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.

Chang AY, Lalia AZ, Jenkins GD, Dutta T, Carter RE, Singh RJ, Nair KS.

Metabolism. 2017 Jun;71:52-63. doi: 10.1016/j.metabol.2017.03.002. Epub 2017 Mar 8.

PMID:
28521878
9.

Metabolic syndrome enhances endoplasmic reticulum, oxidative stress and leukocyte-endothelium interactions in PCOS.

Bañuls C, Rovira-Llopis S, Martinez de Marañon A, Veses S, Jover A, Gomez M, Rocha M, Hernandez-Mijares A, Victor VM.

Metabolism. 2017 Jun;71:153-162. doi: 10.1016/j.metabol.2017.02.012. Epub 2017 Feb 27.

PMID:
28521868
10.

Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome.

Sam S, Vellanki P, Yalamanchi SK, Bergman RN, Dunaif A.

Metabolism. 2017 Jun;71:125-131. doi: 10.1016/j.metabol.2017.03.008. Epub 2017 Mar 22.

PMID:
28521865
11.

Weighing the Impact of Diet and Lifestyle on Female Reproductive Function.

Garruti G, De Palo R, De Angelisc M.

Curr Med Chem. 2017 May 17. doi: 10.2174/0929867324666170518101008. [Epub ahead of print]

PMID:
28521685
12.

Views of women with polycystic ovary syndrome: a qualitative study in an ethnically diverse sample.

Hadjiconstantinou M, Mani H, Patel N, Levy M, Davies MJ, Khunti K, Stone M.

Endocr Connect. 2017 May 17. pii: EC-17-0053. doi: 10.1530/EC-17-0053. [Epub ahead of print]

13.

Pathogenic Anti-Müllerian Hormone Variants in Polycystic Ovary Syndrome.

Gorsic LK, Kosova G, Werstein B, Sisk R, Legro RS, Hayes MG, Teixeira JM, Dunaif A, Urbanek M.

J Clin Endocrinol Metab. 2017 May 12. doi: 10.1210/jc.2017-00612. [Epub ahead of print]

PMID:
28505284
14.

Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.

Caanen MR, Schouten NE, Kuijper EAM, van Rijswijk J, van den Berg MH, van Dulmen-den Broeder E, Overbeek A, van Leeuwen FE, van Trotsenburg M, Lambalk CB.

Hum Reprod. 2017 May 13:1-8. doi: 10.1093/humrep/dex098. [Epub ahead of print]

PMID:
28505246
15.

Significantly lengthened telomere in granulosa cells from women with polycystic ovarian syndrome (PCOS).

Wei D, Xie J, Yin B, Hao H, Song X, Liu Q, Zhang C, Sun Y.

J Assist Reprod Genet. 2017 May 13. doi: 10.1007/s10815-017-0945-z. [Epub ahead of print]

PMID:
28502062
16.

The association of the lipidomic profile with features of polycystic ovary syndrome.

Moran L, Mundra P, Teede H, Miekle PJ.

J Mol Endocrinol. 2017 May 12. pii: JME-17-0023. doi: 10.1530/JME-17-0023. [Epub ahead of print]

PMID:
28500248
17.

Insulin sensitizers in adolescents with polycystic ovary syndrome.

LE TN, Wickham Iii EP, Nestler JE.

Minerva Pediatr. 2017 May 11. doi: 10.23736/S0026-4946.17.04976-3. [Epub ahead of print]

PMID:
28497664
18.

Operative transvaginal hydrolaparoscopy improve ovulation rate after clomiphene failure in polycystic ovary syndrome.

Giampaolino P, De Rosa N, Della Corte L, Morra I, Mercorio A, Nappi C, Bifulco G.

Gynecol Endocrinol. 2017 May 11:1-4. doi: 10.1080/09513590.2017.1323204. [Epub ahead of print]

PMID:
28494682
19.

Medical conditions associated with recurrent miscarriage-Is BMI the tip of the iceberg?

Matjila MJ, Hoffman A, van der Spuy ZM.

Eur J Obstet Gynecol Reprod Biol. 2017 May 3;214:91-96. doi: 10.1016/j.ejogrb.2017.05.003. [Epub ahead of print]

PMID:
28494269
20.

High free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independently of obesity and insulin resistance.

Jie C, Chunhua W, Yi Z, Yuying W, Wendi X, Tzuchun L, Shengxian L, Lihua W, Jun Z, Yun S, Wei L, Tao T.

Int J Obes (Lond). 2017 May 10. doi: 10.1038/ijo.2017.116. [Epub ahead of print]

PMID:
28487551

Supplemental Content

Loading ...
Support Center